4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Edesa Biotech, Inc. (EDSA) operates in the Biotechnology industry and is headquartered in Markham, Canada with about 17 employees. Its market capitalization is roughly $66 million. In the fiscal year ended 2025-09-30, EDSA reported $0M in revenue and ($7M) in net income.
Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases.
Interactive charts & full statements →
| Income statement | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Gross Profit | — | — | — | — | $0M |
| Operating Income (EBIT) | ($7M) | ($6M) | ($9M) | ($18M) | — |
| Net Income | ($7M) | ($6M) | ($8M) | ($18M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($4M) | ($2M) | ($2M) | ($2M) | ($2M) | — |
| Net Income | ($4M) | ($2M) | ($2M) | ($2M) | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Assets | $14M | $4M | $9M | $12M | — |
| Total Liabilities | $1M | $2M | $2M | $2M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive EDSA viewer.
About TickerBase · Data methodology & sources